Technology
KYNDRYL REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
Published
1 year agoon
By
Revenues for the quarter ended March 31, 2025 total $3.8 billion, pretax income is $118 million, net income is $68 million, adjusted EBITDA is $698 million, and adjusted pretax income is $185 millionFiscal year 2025 revenues total $15.1 billion, pretax income is $435 million, net income is $252 million, adjusted EBITDA is $2.5 billion, and adjusted pretax income is $482 millionSignings for fiscal year 2025 were a record $18.2 billion, representing a year-over-year increase of 46%Company provides fiscal year 2026 outlook for positive constant-currency revenue growth, at least $725 million of adjusted pretax income and approximately $550 million of adjusted free cash flow
NEW YORK, May 7, 2025 /PRNewswire/ — Kyndryl (NYSE: KD), a leading provider of mission-critical enterprise technology services, today released financial results for the quarter ended March 31, 2025, the fourth quarter of its 2025 fiscal year.
“Fiscal 2025 was another year of strong execution on our strategy. In addition to returning to constant-currency revenue growth in the fourth quarter, we strengthened our leadership in innovative mission-critical technology services. We expanded our capabilities in cloud, modernization, applications, AI and security, and we further differentiated our services with Kyndryl Bridge,” said Kyndryl Chairman and Chief Executive Officer Martin Schroeter.
“Our fiscal year 2026 outlook for free cash flow growth, earnings growth and constant-currency revenue growth reinforces our confidence to deliver our fiscal year 2028 objectives. Additionally, our ongoing share repurchase program reflects our commitment to returning capital to shareholders, and underscores our strong performance and confidence in the future,” Mr. Schroeter said.
Results for the Fiscal Fourth Quarter Ended March 31, 2025
For the fourth quarter, Kyndryl reported revenues of $3.8 billion, a year-over-year decline of 1% on a reported basis and a year-over-year increase of 1.3% in constant currency. The Company reported pretax income of $118 million, compared to a pretax loss of $4 million in the fourth quarter of 2024. Net income was $68 million, or $0.28 per diluted share, in the quarter, compared to a net loss of $45 million, or ($0.20) per diluted share, in the prior-year period. Cash flow from operations was $581 million.
Adjusted pretax income was $185 million, a 510% increase compared to adjusted pretax income of $30 million in the prior-year period, reflecting contributions from Kyndryl’s three-A initiatives, offset by the contractually required increase in IBM software costs. Adjusted net income was $126 million, or $0.52 per diluted share, compared to an adjusted net loss in the prior-year period. Adjusted EBITDA was $698 million, a 23% year-over-year increase. Adjusted free cash flow was $335 million in the quarter.
Results for the Fiscal Year Ended March 31, 2025
For the fiscal year ended March 31, 2025, Kyndryl reported revenues of $15.1 billion, a year-over-year decline of 6% and 4% in constant currency. The year-over-year constant-currency revenue decline reflects the Company’s progress in reducing inherited no-margin and low-margin third-party content in customer contracts. The Company reported pretax income of $435 million, compared to a pretax loss of $168 million in fiscal year 2024. Net income was $252 million, or $1.05 per diluted share, in the year, compared to a net loss of $340 million, or ($1.48) per diluted share, in the prior year. Cash flow from operations was $942 million.
Adjusted pretax income was $482 million, a 192% increase compared to adjusted pretax income of $165 million in the prior-year period, reflecting contributions from Kyndryl’s three-A initiatives, offset by the contractually required increase in IBM software costs and workforce rebalancing charges. Adjusted net income was $285 million, or $1.19 per diluted share, compared to an adjusted net loss in the prior-year period. Adjusted EBITDA was $2.5 billion, a 6% year-over-year increase. Adjusted free cash flow was $446 million in fiscal year 2025.
Signings for fiscal year 2025 were a record $18.2 billion, representing a year-over-year increase of 46%. The Company’s global signings growth spanned a broad range of industries and included a record 55 contracts in excess of $50 million.
“We delivered strong signings growth in fiscal year 2025, with attractive margins built into these signings. This demonstrates the potential our business has to continue to grow our revenue, increase our earnings and generate cash flow. Our Kyndryl Consult and managed services capabilities align with enterprise customers’ technology needs and are driving incremental, profitable growth opportunities,” said David Wyshner, Kyndryl’s Chief Financial Officer.
Recent Developments
Alliances initiative – In the fourth quarter and the full year, Kyndryl recognized $375 million and $1.2 billion, respectively, in revenue tied to cloud hyperscaler alliances. These amounts are more than double prior-year levels and allowed the Company to exceed its hyperscaler revenue target of nearly $1 billion in fiscal year 2025.Advanced Delivery initiative – The AI-enabled Kyndryl Bridge operating platform is further enhancing the world-class technology services the Company provides and creating additional revenue opportunities. It has also helped Kyndryl free up more than 13,000 delivery professionals. This has generated annualized savings of approximately $775 million as of year-end, ahead of the Company’s $750 million fiscal 2025 year-end goal.Accounts initiative – Kyndryl continued to address elements of contracts with substandard margins, bringing the total impact from this initiative to $900 million of annualized benefits, surpassing the Company’s $850 million fiscal 2025 year-end objective.Strong projected margin on recent signings – In the quarter, projected pretax income margins associated with total signings were in the high-single-digit range, in line with recent quarters, reflecting the Company’s focus on margin expansion.Double-digit growth in Kyndryl Consult – Kyndryl Consult revenues grew 45% year-over-year in the fourth quarter and grew 26% in fiscal 2025. Kyndryl Consult signings grew 37% year-over-year in the fourth quarter and grew 47% in fiscal 2025.Higher cash balance – The Company ended fiscal year 2025 with cash of $1.8 billion and debt of $3.2 billion, resulting in a net debt balance of $1.4 billion.Share repurchases – The Company repurchased 1.8 million shares of its common stock at a cost of $64 million in the fourth quarter, under the $300 million share repurchase program authorized in November 2024.
Fiscal Year 2026 Outlook
Kyndryl is providing the following outlook for its fiscal year 2026, which runs from April 2025 to March 2026:
Adjusted pretax income of at least $725 million, representing a year-over-year increase of at least $243 million.Adjusted EBITDA margin of approximately 18%, representing a year-over-year increase of approximately 130 basis points.Adjusted free cash flow of approximately $550 million, reflecting the Company’s projected adjusted pretax income less cash taxes.
The Company’s earnings and cash flow outlook only assumes constant-currency revenue growth of 1%.
Earnings Webcast
Kyndryl’s earnings call for the fourth fiscal quarter is scheduled to begin at 8:30 a.m. ET on May 8, 2025. The live webcast can be accessed by visiting investors.kyndryl.com on Kyndryl’s investor relations website. A slide presentation will be made available on Kyndryl’s investor relations website before the call on May 8, 2025. Following the event, a replay will be available via webcast for twelve months at investors.kyndryl.com.
About Kyndryl
Kyndryl (NYSE: KD) is a leading provider of mission-critical enterprise technology services offering advisory, implementation and managed service capabilities to thousands of customers in more than 60 countries. As the world’s largest IT infrastructure services provider, the Company designs, builds, manages and modernizes the complex information systems that the world depends on every day. For more information, visit www.kyndryl.com.
Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements concerning the Company’s plans, objectives, goals, beliefs, business strategies, future events, business condition, results of operations, financial position, business outlook and business trends and other non-historical statements, including without limitation the outlook and financial objectives in this press release (which does not assume any future acquisitions or divestitures), are forward-looking statements. Such forward-looking statements often contain words such as “aim,” “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “objectives,” “opportunity,” “plan,” “position,” “predict,” “project,” “should,” “seek,” “target,” “will,” “would” and other similar words or expressions or the negative thereof or other variations thereon. Forward-looking statements are based on the Company’s current assumptions and beliefs regarding future business and financial performance.
The Company’s actual business, financial condition or results of operations may differ materially from those suggested by forward-looking statements as a result of risks and uncertainties which include, among others: failure to attract new customers, retain existing customers or sell additional services to customers; failure to meet growth and productivity objectives; competition; impacts of relationships with critical suppliers and partners; failure to address and adapt to technological developments and trends; inability to attract and retain key personnel and other skilled employees; impact of economic, political, public health and other conditions; damage to the Company’s reputation; inability to accurately estimate the cost of services and the timeline for completion of contracts; service delivery issues; the Company’s ability to successfully manage acquisitions and dispositions, including integration challenges, failure to achieve objectives, the assumption of liabilities and higher debt levels; failure of the Company’s intellectual property rights to prevent competitive offerings and the failure of the Company to obtain, retain and extend necessary licenses; the impairment of our goodwill or long-lived assets; risks relating to cybersecurity, data governance and privacy; risks relating to non-compliance with legal and regulatory requirements; adverse effects from tax matters; legal proceedings and investigatory risks; the impact of changes in market liquidity conditions and customer credit risk on receivables; the Company’s pension plans; the impact of currency fluctuations; and risks related to the Company’s common stock and the securities market.
Additional risks and uncertainties include, among others, those risks and uncertainties described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, and may be further updated from time to time in the Company’s subsequent filings with the Securities and Exchange Commission. Any forward-looking statement in this press release speaks only as of the date on which it is made. Except as required by law, the Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In this release, certain amounts may not add due to the use of rounded numbers; percentages presented are calculated based on the underlying amounts. Forecasted amounts are based on currency exchange rates as of April 2025.
Non-GAAP Financial Measures
In an effort to provide investors with additional information regarding its results, the Company has provided certain metrics that are not calculated based on generally accepted accounting principles (GAAP), such as constant-currency results, adjusted EBITDA, adjusted pretax income, adjusted net income, adjusted EPS, adjusted EBITDA margin, adjusted pretax margin, adjusted net margin, net debt, adjusted operating cash flow and adjusted free cash flow. Such non-GAAP metrics are intended to supplement GAAP metrics, but not to replace them. The Company’s non-GAAP metrics may not be comparable to similarly titled metrics used by other companies. Definitions of non-GAAP metrics and reconciliations of non-GAAP metrics for historical periods to GAAP metrics are included in the tables in this release.
A reconciliation of forward-looking non-GAAP financial information is not included in this release because the Company is unable to predict with reasonable certainty some individual components of such reconciliation without unreasonable effort. These items are uncertain, depend on various factors and could have a material impact on future results computed in accordance with GAAP.
Investor Contact:
investors@kyndryl.com
Media Contact:
press@kyndryl.com
Table 1
CONSOLIDATED INCOME STATEMENT
(in millions, except per share amounts)
Three Months Ended
Year Ended
March 31,
March 31,
2025
2024
2025
2024
Revenues
$
3,800
$
3,850
$
15,057
$
16,052
Cost of services
$
2,975
$
3,134
$
11,914
$
13,189
Selling, general and administrative expenses
640
714
2,591
2,773
Workforce rebalancing charges
23
23
114
138
Transaction-related costs (benefits)
2
(58)
(125)
(46)
Interest expense
23
29
100
122
Other expense
18
11
27
45
Total costs and expenses
$
3,682
$
3,854
$
14,622
$
16,221
Income (loss) before income taxes
$
118
$
(4)
$
435
$
(168)
Provision for income taxes
50
41
184
172
Net income (loss)
$
68
$
(45)
$
252
$
(340)
Earnings per share data
Basic earnings (loss) per share
$
0.30
$
(0.20)
$
1.09
$
(1.48)
Diluted earnings (loss) per share
0.28
(0.20)
1.05
(1.48)
Weighted-average basic shares outstanding
231.4
230.2
231.5
229.2
Weighted-average diluted shares outstanding
241.7
230.2
239.1
229.2
Table 2
SEGMENT RESULTS
AND SELECTED BALANCE SHEET INFORMATION
(dollars in millions)
Three Months Ended March 31,
Year-over-Year Growth
As
Constant
Segment Results
2025
2024
Reported
Currency
Revenue
United States
$
969
$
990
(2 %)
(2 %)
Japan
605
584
4 %
6 %
Principal Markets1
1,273
1,350
(6 %)
(3 %)
Strategic Markets1
953
926
3 %
8 %
Total revenue
$
3,800
$
3,850
(1 %)
1 %
Adjusted EBITDA2
United States
$
228
$
174
Japan
102
83
Principal Markets
231
166
Strategic Markets
161
166
Corporate and other3
(24)
(24)
Total adjusted EBITDA
$
698
$
566
Year Ended March 31,
Year-over-Year Growth
As
Constant
Segment Results
2025
2024
Reported
Currency
Revenue
United States
$
3,876
$
4,295
(10 %)
(10 %)
Japan
2,358
2,344
1 %
6 %
Principal Markets1
5,206
5,479
(5 %)
(4 %)
Strategic Markets1
3,617
3,934
(8 %)
(5 %)
Total revenue
$
15,057
$
16,052
(6 %)
(4 %)
Adjusted EBITDA2
United States
$
725
$
781
Japan
390
361
Principal Markets
886
677
Strategic Markets
606
642
Corporate and other3
(90)
(95)
Total adjusted EBITDA
$
2,516
$
2,367
March 31,
March 31,
Balance Sheet Data
2025
2024
Cash and equivalents
$
1,786
$
1,553
Debt (short-term and long-term)
3,172
3,238
1
Principal Markets is comprised of Kyndryl’s operations in Canada, France, Germany, India, Italy, Spain/Portugal and the United Kingdom/Ireland. Strategic Markets is comprised of Kyndryl’s operations in all other geographic locations. Kyndryl’s operations in Australia/New Zealand transitioned from Principal Markets to Strategic Markets in the quarter ended June 30, 2024; historical segment information has been updated to reflect this change.
2
In the three months ended March 31, 2025, amounts include workforce rebalancing charges of $2 million in United States, $2 million in Japan, $7 million in Principal Markets, and $12 million in Strategic Markets. In the year ended March 31, 2025, amounts include workforce rebalancing charges of $41 million in United States, $6 million in Japan, $23 million in Principal Markets, and $45 million in Strategic Markets.
3
Represents net amounts not allocated to segments.
Table 3
CONSOLIDATED STATEMENT OF CASH FLOWS
(dollars in millions)
Year Ended March 31,
2025
2024
Cash flows from operating activities:
Net income (loss)
$
252
$
(340)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization
Depreciation of property, equipment and capitalized software
660
834
Depreciation of right-of-use assets
327
319
Amortization of transition costs and prepaid software
1,278
1,256
Amortization of capitalized contract costs
420
531
Amortization of acquisition-related intangible assets
30
30
Stock-based compensation
100
95
Deferred taxes
(1)
(13)
Net (gain) loss on asset sales and other
(152)
43
Change in operating assets and liabilities:
Deferred costs (excluding amortization)
(1,762)
(1,569)
Right-of-use assets and liabilities (excluding depreciation)
(314)
(335)
Workforce rebalancing liabilities
(25)
(38)
Receivables
289
11
Accounts payable
(89)
(305)
Taxes
(1)
(2)
Other assets and other liabilities
(71)
(63)
Net cash provided by operating activities
$
942
$
454
Cash flows from investing activities:
Capital expenditures
$
(605)
$
(651)
Proceeds from disposition of property and equipment
83
138
Acquisitions and divestitures, net of cash acquired
139
—
Other investing activities, net
(20)
(40)
Net cash used in investing activities
$
(404)
$
(553)
Cash flows from financing activities:
Debt repayments
$
(148)
$
(644)
Proceeds from issuance of debt, net of debt issuance costs
—
494
Common stock repurchases
(93)
—
Common stock repurchases for tax withholdings
(45)
(22)
Other financing activities, net
—
2
Net cash used in financing activities
$
(286)
$
(170)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
$
(16)
$
(37)
Net change in cash, cash equivalents and restricted cash
$
235
$
(306)
Cash, cash equivalents and restricted cash at beginning of period
$
1,554
$
1,860
Cash, cash equivalents and restricted cash at end of period
$
1,789
$
1,554
Supplemental data
Income taxes paid, net of refunds received
$
149
$
191
Interest paid on debt
$
119
$
118
Net cash provided by operating activities was $581 million in the three months ended March 31, 2025 and $361 million in the nine months ended December 31, 2024.
Table 4
NON-GAAP METRIC DEFINITIONS AND RECONCILIATIONS
(dollars in millions, except signings)
We report our financial results in accordance with GAAP. We also present certain non-GAAP financial measures to provide useful supplemental information to investors. We provide these non-GAAP financial measures as we believe it enhances investors’ visibility to management decisions and their impacts on operational performance; enables better comparison to peer companies; and allows us to provide a long-term strategic view of the business going forward. Moreover, we use certain of these non-GAAP financial metrics in measuring performance under our executive compensation plans.
Constant-currency information compares results between periods as if exchange rates had remained constant period over period. We define constant-currency revenues as total revenues excluding the impact of foreign exchange rate movements and use it to determine the constant-currency revenue growth on a year-over-year basis. Constant-currency revenues are calculated by translating current period revenues using corresponding prior-period exchange rates.
Adjusted pretax income is defined as pretax income excluding transaction-related costs and benefits, charges related to ceasing to use leased / fixed assets, charges related to lease terminations, pension costs other than pension servicing costs and multi-employer plan costs, stock-based compensation expense, amortization of acquisition-related intangible assets, workforce rebalancing charges incurred prior to March 31, 2024, impairment expense, significant litigation costs and benefits, and currency impacts of highly inflationary countries. Adjusted pretax margin is calculated by dividing adjusted pretax income by revenue.
Adjusted EBITDA is defined as net income (loss) excluding net interest expense, income taxes, depreciation and amortization (excluding depreciation of right-of-use assets and amortization of capitalized contract costs), charges related to ceasing to use leased / fixed assets, charges related to lease terminations, transaction-related costs and benefits, pension costs other than pension servicing costs and multi-employer plan costs, stock-based compensation expense, workforce rebalancing charges incurred prior to March 31, 2024, impairment expense, significant litigation costs and benefits, and currency impacts of highly inflationary countries. Adjusted EBITDA margin is calculated by dividing adjusted EBITDA by revenue.
Adjusted net income is defined as adjusted pretax income less the reported provision for income taxes, minus or plus the tax effect of the non-GAAP adjustments made to calculate adjusted pretax income, and excluding exceptional items impacting the reported provision for income taxes. Adjusted net margin is calculated by dividing adjusted net income by revenue.
Adjusted earnings per share (EPS) is defined as adjusted net income divided by diluted weighted average shares outstanding to reflect shares that are dilutive or anti-dilutive based on the amount of adjusted net income. The weighted average common shares outstanding used to calculate adjusted earnings (loss) per share will differ from such shares used to calculate diluted earnings (loss) per share (GAAP) when the inclusion of dilutive shares has an anti-dilutive effect for one calculation but not for the other.
Adjusted free cash flow is defined as cash flows from operating activities (GAAP) after adding back transaction-related payments, charges related to lease terminations, payments related to workforce rebalancing charges incurred prior to March 31, 2024, and significant litigation payments (collectively referred to as adjusted operating cash flow), less net capital expenditures. Management uses adjusted operating cash flow and adjusted free cash flow as measures to evaluate our operating results, plan strategic investments and assess our ability and need to incur and service debt. We believe adjusted operating cash flow and adjusted free cash flow are useful supplemental financial measures to aid investors in assessing our ability to pursue business opportunities and investments and to service our debt. Adjusted operating cash flow and adjusted free cash flow are financial measures that are not recognized under U.S. GAAP and should not be considered as an alternative to cash flows from operations or liquidity derived in accordance with U.S. GAAP.
Signings are defined by Kyndryl as an initial estimate of the value of a customer’s commitment under a contract. The calculation involves estimates and judgments to gauge the extent of a customer’s commitment. We calculate this based on various considerations including the type and duration of the agreement as well as the presence of termination charges or wind-down costs. Contract extensions and increases in scope are treated as signings only to the extent of the incremental new value. Signings can vary over time due to a variety of factors including, but not limited to, the timing of signing a small number of larger outsourcing contracts, as well as the length of those contracts. The conversion of signings into revenue may vary based on the types of services and solutions, customer decisions and other factors, which may include, but are not limited to, macroeconomic environment or external events. Management uses signings as a tool to monitor the performance of the business including the business’ ability to attract new customers and sell additional scope into our existing customer base.
Reconciliation of net income (loss)
to adjusted pretax income,
adjusted EBITDA, adjusted net
Three Months Ended
Year Ended
income (loss) and adjusted EPS
March 31,
March 31,
(in millions, except per share amounts)
2025
2024
2025
2024
Net income (loss) (GAAP)
$
68
$
(45)
$
252
$
(340)
Provision for income taxes
50
41
184
172
Pretax income (loss) (GAAP)
$
118
$
(4)
$
435
$
(168)
Workforce rebalancing charges incurred prior to March 31, 2024
—
23
—
138
Charges related to ceasing to use leased/fixed assets and lease terminations
19
14
48
39
Transaction-related costs (benefits)1
2
(58)
(125)
(46)
Stock-based compensation expense
22
22
100
95
Amortization of acquisition-related intangible assets
7
7
30
30
Other adjustments2
17
25
(6)
78
Adjusted pretax income (non-GAAP)
$
185
$
30
$
482
$
165
Interest expense
23
29
100
122
Depreciation of property, equipment and capitalized software3
186
195
656
824
Amortization of transition costs and prepaid software
304
311
1,278
1,256
Adjusted EBITDA (non-GAAP)
$
698
$
566
$
2,516
$
2,367
Net income margin
1.8 %
(1.2) %
1.7 %
(2.1) %
Adjusted EBITDA margin
18.4 %
14.7 %
16.7 %
14.7 %
Adjusted pretax income (non-GAAP)
$
185
$
30
$
482
$
165
Provision for income taxes (GAAP)
(50)
(41)
(184)
(172)
Tax effect of non-GAAP adjustments
(9)
9
(14)
(18)
Adjusted net income (loss) (non-GAAP)
$
126
$
(2)
$
285
$
(25)
Diluted weighted average shares outstanding for calculating adjusted EPS
241.7
230.2
239.1
229.2
Diluted earnings (loss) per share (GAAP)
$
0.28
$
(0.20)
$
1.05
$
(1.48)
Adjusted earnings (loss) per share (non-GAAP)
$
0.52
$
(0.01)
$
1.19
$
(0.11)
1
Kyndryl’s reported results for the year ended March 31, 2025 include a transaction-related gain of $145 million pretax ($138 million after-tax) related to the Company’s divestiture of its Securities Industry Services platform in Canada. The divestiture reduced the Company’s reported revenue from the divestiture date forward.
2
Other adjustments represent pension costs other than pension servicing costs and multi-employer plan costs, significant litigation costs and benefits, and currency impacts of highly inflationary countries.
3
Amount for the year ended March 31, 2024 excludes $10 million of expense that is included in transaction-related costs and benefits.
Reconciliation of cash flow from operations
Three Months Ended
Year Ended
to adjusted operating cash flow and
March 31,
March 31,
adjusted free cash flow (in millions)
2025
2024
2025
2024
Cash flows from operating activities (GAAP)
$
581
$
145
$
942
$
454
Plus: Transaction-related payments (benefits)
(19)
(6)
(14)
106
Plus: Workforce rebalancing payments related to
charges incurred prior to March 31, 2024
—
34
25
176
Plus: Significant litigation payments
1
6
15
61
Plus: Payments related to lease terminations
—
—
—
7
Adjusted operating cash flow (non-GAAP)
$
563
$
179
$
968
$
804
Less: Net capital expenditures
(228)
(199)
(522)
(513)
Adjusted free cash flow (non-GAAP)
$
335
$
(20)
$
446
$
291
Three Months Ended
Year Ended
March 31,
March 31,
Signings (in billions)
2025
2024
2025
2024
Signings1
$
5.5
$
3.6
$
18.2
$
12.5
1
Signings for the three months ended March 31, 2025 increased by 53%, and 55% in constant currency, compared to the three months ended March 31, 2024. Signings for the year ended March 31, 2025 increased by 46%, and 48% in constant currency, compared to the year ended March 31, 2024.
View original content to download multimedia:https://www.prnewswire.com/news-releases/kyndryl-reports-fourth-quarter-and-full-year-2025-results-302449070.html
SOURCE Kyndryl
You may like
Technology
Healthcare Data Center Market to Reach USD 37.11 Billion by 2035 as AI Genomics, EHR Resilience and Hosted Capacity Reshape Healthcare Infrastructure – DC Market Insights
Published
9 minutes agoon
October 23, 2026By
Market grows at a 9.15% CAGR from USD 15.46 billion in 2025; AI genomics and research computing expands 16.71% a year, while North America holds 46.0% of spending
LONDON, Oct. 23, 2026 /PRNewswire/ — The “Healthcare Data Center Market – Growth, Share, Opportunities & Competitive Analysis, 2026-2035” report has been added to the DC Market Insights offering. The global Healthcare Data Center Market was valued at USD 15.46 billion in 2025, is estimated at USD 17.34 billion in 2026, and is projected to reach USD 37.11 billion by 2035, growing at a CAGR of 9.15% from 2025 to 2035. DC Market Insights finds that healthcare infrastructure is splitting between general-purpose EHR workloads that increasingly move to hosted environments and higher-value AI, imaging, research and resilience workloads that require dedicated or colocated capacity.
Healthcare Data Center Market at a Glance
Metric
Value (DC Market Insights estimate)
Market size, 2020
USD 9.77 billion
Market size, 2025 (base year)
USD 15.46 billion
Market size, 2026
USD 17.34 billion (+12.16% year on year)
Market size, 2030
USD 25.10 billion
Market size, 2035
USD 37.11 billion
CAGR 2025-2035
9.15% (low case 7.13%, high case 10.69%)
Largest component
IT hardware, 70.7% of 2025 value
Fastest-growing workload
AI genomics and research computing, 16.71% CAGR
Leading region
North America, 46.0% (USD 7.11 billion)
Fastest-growing region
Asia Pacific, 11.72% CAGR
Largest end user
Hospitals and health systems, 47.0% of 2025 value
Key Takeaways
IT hardware accounts for USD 10.93 billion, or 70.7% of 2025 market value, reflecting the high server, storage and accelerator content of clinical and research workloads.AI genomics and research computing is the fastest workload, rising 16.71% a year from USD 2.30 billion in 2025 to USD 10.78 billion by 2035.Hospitals and health systems remain the largest end user at USD 7.27 billion in 2025, while pharmaceutical and life sciences grows fastest among end users at 11.61% a year.On-premises owned sites hold 60.0% of 2025 value, but wholesale and build-to-suit grows 14.01% a year as research and AI clusters move into purpose-built capacity.North America leads with 46.0% of 2025 spending, while Asia Pacific grows fastest at 11.72%; India is the fastest-growing large country at 18.37% a year.
Scope & Segmentation – Healthcare Data Center Market
The report analyzes the market across the following segments:
Component: IT Hardware; Colocation and Hosting Services; Electrical and Mechanical Infrastructure; Construction and Fit-OutEnd User: Hospitals and Health Systems; Pharmaceutical and Life Sciences; Payers and Health Insurers; Health IT and Medtech Vendors; Public Health and Research InstitutesWorkload: EHR and Clinical Applications; Medical Imaging and PACS; AI Genomics and Research Computing; Claims and Revenue Cycle; Backup and Disaster Recovery; Collaboration and Other WorkloadsDeployment Model: On-Premises Owned Sites; Retail Colocation; Wholesale and Build-to-Suit; Vendor-Hosted Private CloudGeography: North America; Europe; Asia Pacific; Latin America; Middle East and Africa, with 12 country forecasts
Report Updated: Oct. 22, 2026
Get Free Sample Report – Healthcare Data Center Market
“Healthcare data center demand is moving in two directions at once: hospitals are reducing general-purpose owned halls while AI, imaging, research and cyber-resilience requirements add denser, higher-value infrastructure. Our model shows AI genomics and research computing growing 16.71% a year and wholesale or build-to-suit capacity growing 14.01%, while the owned-site share falls from 60.0% in 2025 toward 45.0% by 2035. That makes compliant hosted capacity, AI-ready infrastructure and recoverability the strongest growth pools through the forecast period.”
— Amit Jain, Senior Consultant, ICT & Emerging Technologies, DC Market Insights, report author
Why This Report Matters
Healthcare data centers sit at the intersection of patient-data availability, clinical application performance, medical imaging, pharmaceutical research and cyber resilience. The report helps health systems, life sciences companies, colocation operators, cloud and hosting providers, equipment vendors and investors size infrastructure demand while separating public-cloud migrations that leave the market from leased and owned capacity that remains in scope.
Key Attributes
Report attribute
Details
Historical Period
2020-2024
Base Year
2025
Forecast Period
2026-2035
Market Size 2025
USD 15.46 billion
Market Size 2026
USD 17.34 billion
Market Size 2035
USD 37.11 billion
CAGR 2025-2035
9.15% (low 7.13%, high 10.69%)
Leading Region
North America, 46.0%
Report Format
PDF + Excel
How Big Is the Healthcare Data Center Market in 2026?
DC Market Insights values the Healthcare Data Center Market at USD 17.34 billion in 2026, 12.16% above 2025, as backup sites, AI clusters for drug discovery and leased halls for electronic health records are added faster than hospital server rooms close. The model places healthcare IT load at 3,300 MW in 2025 and projects it to double to 6,600 MW by 2035, with accelerator racks taking a larger share of the mix.
Year
Market size
2020
USD 9.77 billion
2025
USD 15.46 billion
2026
USD 17.34 billion (+12.16% year on year)
2030
USD 25.10 billion
2035
USD 37.11 billion
Source: DC Market Insights, Healthcare Data Center Market report, Oct. 22, 2026.
Why Do AI and Research Workloads Raise Healthcare Data Center Spend?
AI infrastructure changes the value of each megawatt. DC Market Insights estimates a conventional healthcare MW carries about USD 3.05 million a year of hardware, while an AI MW carries about USD 8.30 million. That premium comes from GPU systems, high-speed networking, large research datasets and the supporting power and cooling required for accelerated computing. The result is that market value grows faster than healthcare IT load as the accelerator share rises from about 5% in 2025 toward 22% by 2035.
Which Component Leads Healthcare Data Center Spending?
IT hardware remains the largest component, but colocation and hosting services grow faster as providers absorb EHR, imaging, backup and research workloads that institutions no longer want to operate in ageing hospital server rooms.
Component
2025 value
Share 2025
2035 value
CAGR
IT Hardware
USD 10,931.24M
70.7 %
USD 24,479.40M
8.40 %
Colocation and Hosting Services
USD 3,136.32M
20.3 %
USD 9,496.08M
11.72 %
Electrical and Mechanical Infrastructure
USD 967.87M
6.3 %
USD 2,058.14M
7.84 %
Construction and Fit-Out
USD 427.77M
2.8 %
USD 1,078.98M
9.69 %
DC Exclusive: Hospital Data Center Exit Tracker
DC Market Insights tracks 14 named healthcare infrastructure moves from 2014 through 2026. Ten moved workloads to public cloud, two went to colocation and two built new owned sites. The pattern explains why owned data centers can lose share even while the overall market expands: general-purpose EHR estates leave older halls, while AI and research clusters arrive as new owned, wholesale or colocated capacity. The model therefore takes the owned-site share from 60.0% in 2025 toward 45.0% by 2035.
Workload
2025 value
Share 2025
2035 value
CAGR
EHR and Clinical Applications
USD 4,638.95M
30.0 %
USD 8,907.02M
6.74 %
Medical Imaging and PACS
USD 2,783.38M
18.0 %
USD 6,309.14M
8.53 %
AI Genomics and Research Computing
USD 2,297.83M
14.9 %
USD 10,777.50M
16.71 %
Claims and Revenue Cycle
USD 2,010.22M
13.0 %
USD 4,082.39M
7.34 %
Backup and Disaster Recovery
USD 2,164.85M
14.0 %
USD 4,453.51M
7.48 %
Collaboration and Other Workloads
USD 1,567.97M
10.1 %
USD 2,583.04M
5.12 %
Which Region Leads the Healthcare Data Center Market?
North America leads because the United States combines a large installed hospital base, near-universal certified EHR adoption and significant pharmaceutical research infrastructure. Asia Pacific grows fastest as India, China and other markets add local capacity under health-data localization and digital-health programs.
Indicator
2025 / Base
Outlook
Leading region
North America, 46.0% (USD 7.11B)
USD 15.77B by 2035; remains the largest regional spending pool
Fastest-growing region
Asia Pacific, 11.72% CAGR
Reaches USD 9.83B by 2035 as India and China add domestic health-data capacity
Fastest large country
India, 18.37% CAGR
USD 247.41M in 2025 to USD 1.34B by 2035
Largest country
United States, USD 6.49B in 2025
Remains the largest national market through the forecast
How Could the 2035 Forecast Change?
The 2035 outcome depends on how quickly hospital EHR estates move to public cloud, how much pharmaceutical AI is purchased as cloud capacity rather than dedicated infrastructure, and how strongly resilience rules push institutions to maintain recoverable private or colocated capacity.
Scenario
Assumption
2035 value
CAGR 2025-2035
Low
Faster EHR migration to public cloud; more pharma AI bought as cloud capacity
USD 30.80B
7.13 %
Base
Healthcare IT load reaches 6,600 MW; 22% on AI racks; 55% leased
USD 37.11B
9.15 %
High
Stricter 72-hour restore requirements and more drug makers build owned AI factories
USD 42.68B
10.69 %
Competitive Landscape and Recent Developments
The five largest colocation providers account for about 31% of the USD 3.14 billion healthcare colocation and hosting market in 2025, leaving the sector fragmented. Competition spans colocation, EHR hosting, cloud services, AI hardware and the power and cooling systems required for hospital and life-sciences infrastructure.
Companies profiled include:
Equinix; Digital Realty; Iron Mountain Data Centers; CyrusOne; NTT DATA; Epic Systems (Epic Hosting); Oracle (Oracle Health); Microsoft (Nuance); Amazon Web Services; Google Cloud; Dell Technologies; Hewlett Packard Enterprise; NVIDIA; Cisco Systems; Schneider Electric; Vertiv.
In July 2026, WellSpan Health completed the move of more than 300 applications and 7.5 PB of data to AWS in 17 weeks.In April 2026, the U.S. Department of Veterans Affairs requested USD 4.2 billion for its EHR in fiscal 2027, including USD 745 million for infrastructure readiness.In February 2026, Eli Lilly’s LillyPod AI factory with more than 9,000 petaflops went live in Indianapolis.In February 2026, five Ontario hospitals in Transform Shared Service Organization moved their EHR to Oracle Cloud Infrastructure, cutting page-load time by 71%.In January 2026, NVIDIA and Eli Lilly agreed to invest up to USD 1 billion over five years in an AI co-innovation lab.In November 2025, India notified the DPDP Rules with an 18-month phased timeline.
Frequently Asked Questions
What is the size of the Healthcare Data Center Market?
USD 15.46 billion in 2025 and USD 17.34 billion in 2026, projected to reach USD 37.11 billion by 2035 at a 9.15% CAGR.
Which component leads the market?
IT hardware, with USD 10.93 billion or 70.7% of 2025 spending.
Which workload grows fastest?
AI genomics and research computing, at 16.71% a year through 2035.
Which healthcare end user spends the most?
Hospitals and health systems, with USD 7.27 billion or 47.0% of 2025 market value.
Which region leads?
North America with USD 7.11 billion or 46.0% of 2025 value; Asia Pacific grows fastest at 11.72% a year.
Who are the leading suppliers?
Equinix, Digital Realty, Iron Mountain Data Centers, CyrusOne and NTT DATA are among the leading colocation providers, alongside major healthcare hosting, cloud, hardware and infrastructure vendors.
Methodology
DC Market Insights builds the healthcare data center market bottom-up from 3,300 MW of healthcare IT load in 2025 and spending per MW for hardware, colocation and hosting, electrical and mechanical infrastructure, and construction and fit-out. The model separates conventional and AI MW, applies leased-capacity economics, and reconciles end-user, workload, deployment, regional and country splits to the total market before applying forecast assumptions.
Download Sample Report – Healthcare Data Center Market
Related Reports from DC Market Insights
Data Center Colocation Market
AI Data Center Market
Data Center Outsourcing Market
Multi-Tenant Data Center Market
Data Center Virtualization Market
DC Market Insights Data & Tools
Explore live datasets and decision tools used across DC Market Insights research:
Data Center Database
Data Center Map
Data Center Operators
Global Capacity Tracker
Deal Tracker
Power & Policy Tracker
PUE Calculator
Construction Pipeline
Deal Comps
Site Risk
Electricity Rates
Data Center Footprint
About DC Market Insights
DC Market Insights is a dedicated research and consulting firm that empowers data center leaders with actionable intelligence. We combine rigorous market research, advanced analytics and practical advisory support to help organizations make confident decisions in an increasingly complex digital infrastructure landscape. Our goal is to transform data into clarity, giving clients the ability to act decisively on strategy, investment and execution.
Contact Us
DC Market Insights
Tower C-1105, S 25, Akash Tower, Vishal Nagar, Pimple Nilakh, Haveli, Pune – 411027, India
Email: sales@dcmarketinsights.com
United States: +1 628 262 7656
United Kingdom: +44 7453 598 606
Web: www.dcmarketinsights.com
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/healthcare-data-center-market-to-reach-usd-37-11-billion-by-2035-as-ai-genomics-ehr-resilience-and-hosted-capacity-reshape-healthcare-infrastructure—dc-market-insights-302918129.html
Technology
City of Hope Cancer Center Chicago Unites Industry Leaders for Health Technology Innovation Roundtable
Published
9 minutes agoon
October 23, 2026By
CHICAGO, Oct. 23, 2026 /PRNewswire/ — Faster access to care, more affordable treatment and policies that support innovation were central themes of a Health Technology Innovation Roundtable convened by City of Hope® Cancer Center Chicago on Thursday, October 15, at its hospital in Zion.
The discussion brought together Congressman Brad Schneider (IL-10) and leaders from City of Hope, Vantive and Zocdoc to examine how technology can help bend the health care cost curve, connect patients with care sooner and expand access to specialized treatment.
“Thank you to City of Hope in Zion for graciously hosting our recent roundtable to discuss how emerging health technologies are shaping patient care, access, and affordability,” said Schneider. “I am proud to represent a district where so many people work in the life sciences field to advance innovation. This convening was an important opportunity to hear directly from health technology innovators about the progress they are making to better connect patients with lifesaving care and how we can work together. I will continue to partner with City of Hope and the health technology experts throughout our district to ensure more people have access to the cutting-edge treatment and testing they deserve.”
The conversation spanned digital appointment scheduling, home dialysis, surgical robotics, artificial intelligence and remote monitoring. Zocdoc’s digital marketplace connects patients with available appointments, helping fill openings that might otherwise go unused. Vantive’s work in kidney care, including home dialysis, illustrated how technology can expand options for where and how patients receive treatment. City of Hope’s experience with advanced surgery and wearable devices highlighted opportunities to bring specialized expertise closer to patients and support recovery at home.
“Technological advancements continue to evolve rapidly, and keeping up with them can feel like a job unto itself,” said Pete Govorchin, president of City of Hope Chicago. “Having an opportunity to pause and reflect on the progress we have seen thus far, as well as look ahead to what’s next alongside a distinguished panel of respected professionals, is critical.”
The discussion also addressed barriers that can keep innovation from reaching patients, including state licensing requirements, limited broadband, outdated regulations and reimbursement challenges. Access for rural communities and veterans was a recurring concern, alongside the need to measure how new technologies improve outcomes and reduce avoidable costs.
“As both a developer and adopter of advanced surgical technologies, City of Hope is well positioned to provide practical, evidence-based insights into how robotic surgery and other procedures, delivered remotely, could improve access, enhance quality, and support the future of patient-centered care,” said Dr. Yuman Fong, a City of Hope surgical oncologist.
Joining Schneider, Govorchin and Fong were Chris Toth, CEO of Vantive; Kyle Jackson, Vantive’s executive director of government affairs and market development; and Ilyssa Meyer, Zocdoc’s director of government affairs.
“I was proud to be part of an important convening of health technology experts discussing how we can continue to work together to connect more patients to care and innovative treatment. Rep. Schneider’s leadership on the bipartisan, bicameral Health ACCESS Act is an important next step in turning the innovations discussed at the recent roundtable into broader access to care,” added Meyer. “By reducing barriers to digital health services and online appointment scheduling, the bill can help connect more patients with the care they need.”
About City of Hope
City of Hope’s mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the United States, and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation’s top cancer centers by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, Orange County, California, campus, a network of clinical care locations across Southern California and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHope™. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/city-of-hope-cancer-center-chicago-unites-industry-leaders-for-health-technology-innovation-roundtable-302917568.html
SOURCE City of Hope Cancer Center Chicago
Technology
Kin Becomes First U.S. Home Insurer to Enable WebMCP for AI Shopping
Published
9 minutes agoon
October 23, 2026By
Consumers can now use ChatGPT to efficiently shop Kin’s digital home insurance experience
CHICAGO, Oct. 23, 2026 /PRNewswire/ — Building on its recent announcement that AI shopping agents like Meta’s Muse are welcome to shop on Kin.com, Kin is making its digital home insurance experience even easier for AI to shop. Kin, the direct-to-consumer provider of insurance and home finance solutions for homeowners, today announced that it has enabled WebMCP in its digital quoting experience. The new capability gives ChatGPT a faster and more efficient way to interact with Kin.com on a consumer’s behalf.
Homeowners can go from their AI agent prompt to a customized Kin home insurance quote ready for purchase in minutes due to the data-informed Kin.com quoting process.
“We said that Kin will win the AI shopping experience, and we meant it,” said Kin Founder and CEO Sean Harper. “People are going to increasingly ask AI to do the tedious work of shopping for them. We want someone to be able to tell ChatGPT, ‘Help me shop for home insurance,’ and make it incredibly easy for that AI agent to shop Kin.”
Unlike plug-ins that require installation, WebMCP is an open web standard which lets AI agents work directly with Kin.com, creating a more efficient way to interact with Kin’s digital experience, and making it easier for them to help consumers shop for home insurance. For consumers, that means AI can do more of the repetitive work involved in insurance shopping, while Kin makes its experience easier for those AI agents to navigate.
Built for the Way Consumers Will Shop
The launch builds on Kin’s announcement that it would welcome Meta’s Muse and other AI shopping agents to Kin.com rather than block them. In Kin’s testing, Muse was able to retrieve home insurance quotes after asking consumers only a handful of questions. Likewise, with ChatGPT, Kin testing found consumers could easily price out home insurance in a clear side-by-side view with minimal questions. The technology improves daily, and Kin is committed to implementing open standards like WebMCP, which ChatGPT supports for paid users on its browser-based platform. While free ChatGPT accounts cannot use this protocol, consumers can still easily get a quote at kin.com.
Kin was built to sell home insurance directly to consumers through a digital experience, without relying on external agents. It also analyzes thousands of data points about individual homes, meaning much of the information needed to generate a quote can already be gathered without asking the homeowner.
“We didn’t have to reinvent Kin for AI shopping,” Harper said. “We already built a direct digital experience, we already have the data to answer most of the questions about a home, and we don’t depend on someone in the middle to sell the product. AI shopping rewards a lot of the things we’ve been building for years.”
A New Way to Shop for Insurance
Kin expects AI agents to become increasingly capable of helping consumers gather information, understand coverage and shop across insurance providers. As those capabilities improve, Kin plans to continue making its digital experience easier for both people and the AI agents working on their behalf.
“Five years from now, opening a bunch of browser tabs and filling out the same information over and over is going to seem pretty antiquated,” Harper said. “You’ll tell your AI what you need and it will go do the work. We’ve built Kin to win in that world.”
About Kin
Kin helps homeowners save money, simplify tasks, and protect their most valuable assets. By offering direct-to-consumer digital home and auto insurance alongside home finance services, the company focuses on supporting underserved homeowners in states with high catastrophic risk. Kin provides more convenient and affordable home and auto insurance coverage by eliminating the need for external agents and analyzing thousands of data points to provide transparent, accurate pricing. Kin’s AI-native technology platform delivers a seamless customer experience, customized options, and fast, high-quality service. To learn more, visit www.kin.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/kin-becomes-first-us-home-insurer-to-enable-webmcp-for-ai-shopping-302917809.html
SOURCE Kin Insurance, Inc.
Healthcare Data Center Market to Reach USD 37.11 Billion by 2035 as AI Genomics, EHR Resilience and Hosted Capacity Reshape Healthcare Infrastructure – DC Market Insights
City of Hope Cancer Center Chicago Unites Industry Leaders for Health Technology Innovation Roundtable
Kin Becomes First U.S. Home Insurer to Enable WebMCP for AI Shopping
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology4 days agoGMIF2026: AI Inference Powers the “Token Factory” and Drives System-Level Rethinking of Memory & Storage
-
Technology4 days agoInstaMall Launches Same-Day Fashion Delivery Experience, Bringing 80+ Brands to Shoppers’ Doors in Miami
-
Coin Market4 days agoWorld Liberty’s USD1 stablecoin sheds $400M in market cap in two weeks
-
Technology4 days agoHISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES
-
Technology4 days agoTruecaller announces preliminary numbers for the third quarter 2026
-
Technology4 days agoSALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
-
Technology4 days agoTrend Micro Announces Up to ¥10 Billion toward Cyber Resilience Initiative to Strengthen Security for Japanese Organizations in the AI Era
-
Technology4 days agoTreasuries Rallied as Tech Slid, and the Crowded Bet Against Bonds Felt It
